BioSpace News Archive

Agile Therapeutics, Inc., a women’s healthcare company, announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, plans to release its third quarter 2021 results after the financial markets close on Wednesday, November 3, 2021.

Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), today announced that it will host an Investor and Analyst call and webcast on Tuesday, October 12, 2021.

Takeda Pharmaceutical Company Limited announced the U.S. Food and Drug Administration Antimicrobial Drugs Advisory Committee voted unanimously to recommend use of maribavir for the treatment of refractory cytomegalovirus infection and disease with genotypic resistance to ganciclovir, valganciclovir, foscarnet or cidofovir in transplant recipients.

Rain Therapeutics Inc.,, a late-stage company developing precision oncology therapeutics, announced data on its oral mouse double minute 2 inhibitor, milademetan, presented at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics held virtually October 7-10, 2021.

Jaguar Health, Inc. provided updates regarding ongoing research and development related to the company’s crofelemer drug product candidates, and also announced that Dragon SPAC S.p.A. and Napo EU S.p.A., the company’s Italian subsidiary, have submitted the required notification in order to have the impending merger of Dragon SPAC and Napo EU approved as required by Italy’s laws.

MustGrow has closed on an aggregate of 2,726,611 units for gross proceeds of C$7,089,189 effective October 6, 2021.

LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing bispecific gamma delta T cell engagers (bsTCEs) to transform the treatment of cancer, today announced that Hans van der Vliet, M.D,. Ph.D., chief scientific officer at LAVA, will present at the AACR-NCI-EORTC Virtual International Conference.

Cerner Corporation, a global healthcare technology company, will host its annual Cerner Health Conference, next week, Oct. 12-13, kicking off with Dr. David Feinberg, Cerner’s new president and CEO.

Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that preliminary clinical results from its first-in-human study of the Amplifi™ Vein Dilation System were presented at the 2021 Vascular Interventional Advances (VIVA) conference.